• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

呋喃妥因作为甲硝唑替代药物用于幽门螺杆菌联合抗菌治疗的体外评价

In-vitro evaluation of nitrofurantoin as an alternative agent for metronidazole in combination antimicrobial therapy against Helicobacter pylori.

作者信息

Coudron P E, Stratton C W

机构信息

Pathology and Laboratory Medicine Service, McGuire Veterans Affairs Medical Center, Richmond, VA 23249-0001, USA.

出版信息

J Antimicrob Chemother. 1998 Nov;42(5):657-60. doi: 10.1093/jac/42.5.657.

DOI:10.1093/jac/42.5.657
PMID:9848452
Abstract

Increasing metronidazole resistance suggests the need for alternative antibiotics for combination therapy of Helicobacter pylori infections. We evaluated a metronidazole-resistant and a clarithromycin-resistant strain of H. pylori under stationary growth phase conditions that favoured physiological conditions in order to determine if nitrofurantoin might be a suitable alternative for metronidazole in combination therapy. The results demonstrated that the triple combination of bismuth, tetracycline and nitrofurantoin achieved greater bactericidal activity against these two strains than did the combination of bismuth, tetracycline and metronidazole. These results suggest that further evaluation is warranted.

摘要

甲硝唑耐药性的增加表明,在幽门螺杆菌感染的联合治疗中需要使用替代抗生素。我们在有利于生理条件的稳定生长期条件下,评估了一株甲硝唑耐药和一株克拉霉素耐药的幽门螺杆菌菌株,以确定呋喃妥因是否可能是联合治疗中甲硝唑的合适替代品。结果表明,铋剂、四环素和呋喃妥因的三联组合对这两种菌株的杀菌活性比铋剂、四环素和甲硝唑的组合更强。这些结果表明有必要进行进一步评估。

相似文献

1
In-vitro evaluation of nitrofurantoin as an alternative agent for metronidazole in combination antimicrobial therapy against Helicobacter pylori.呋喃妥因作为甲硝唑替代药物用于幽门螺杆菌联合抗菌治疗的体外评价
J Antimicrob Chemother. 1998 Nov;42(5):657-60. doi: 10.1093/jac/42.5.657.
2
Nitrofurantoin quadruple therapy for Helicobacter pylori infection: effect of metronidazole resistance.用于幽门螺杆菌感染的呋喃妥因四联疗法:甲硝唑耐药性的影响
Aliment Pharmacol Ther. 2001 Apr;15(4):513-8. doi: 10.1046/j.1365-2036.2001.00945.x.
3
A randomized trial of lansoprazole, amoxycillin, and clarithromycin versus lansoprazole, bismuth, metronidazole and tetracycline in the retreatment of patients failing initial Helicobacter pylori therapy.兰索拉唑、阿莫西林和克拉霉素与兰索拉唑、铋剂、甲硝唑和四环素用于初次幽门螺杆菌治疗失败患者再治疗的随机试验。
Dig Dis. 2001;19(2):174-8. doi: 10.1159/000050674.
4
An increase in Helicobacter pylori strains resistant to metronidazole: a five-year study.幽门螺杆菌对甲硝唑耐药菌株的增加:一项为期五年的研究。
Helicobacter. 1996 Mar;1(1):57-61. doi: 10.1111/j.1523-5378.1996.tb00009.x.
5
[In vitro antimicrobial susceptibility of Helicobacter pylori strains: isolation of strains resistant to clarithromycin].幽门螺杆菌菌株的体外抗菌药敏性:对克拉霉素耐药菌株的分离
Rev Med Chil. 2001 Jun;129(6):643-6.
6
Role of Bismuth in the Eradication of Helicobacter pylori.铋在根除幽门螺杆菌中的作用。
Am J Ther. 2017 Nov/Dec;24(6):e751-e757. doi: 10.1097/MJT.0000000000000389.
7
Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxycillin, tetracycline and trovafloxacin in The Netherlands.荷兰幽门螺杆菌对甲硝唑、克拉霉素、阿莫西林、四环素和曲伐沙星的耐药率
J Antimicrob Chemother. 1999 Apr;43(4):511-5. doi: 10.1093/jac/43.4.511.
8
Efficacy of bismuth-containing quadruple therapies for clarithromycin-, metronidazole-, and fluoroquinolone-resistant Helicobacter pylori infections in a prospective study.前瞻性研究中含铋四联疗法对克拉霉素、甲硝唑和氟喹诺酮耐药幽门螺杆菌感染的疗效。
Clin Gastroenterol Hepatol. 2013 Jul;11(7):802-7.e1. doi: 10.1016/j.cgh.2013.01.008. Epub 2013 Jan 29.
9
Resistance rate to antibiotics of Helicobacter pylori isolates in eastern Taiwan.台湾东部幽门螺杆菌分离株的抗生素耐药率。
J Gastroenterol Hepatol. 2007 May;22(5):720-3. doi: 10.1111/j.1440-1746.2006.04743.x.
10
Primary and combined resistance to four antimicrobial agents in Helicobacter pylori in Sofia, Bulgaria.保加利亚索非亚幽门螺杆菌对四种抗菌药物的原发性和联合耐药性
J Med Microbiol. 2000 May;49(5):415-418. doi: 10.1099/0022-1317-49-5-415.

引用本文的文献

1
Second-line and third-line trial for helicobacter pylori infection in patients with duodenal ulcers: A prospective, crossover, controlled study.十二指肠溃疡患者幽门螺杆菌感染的二线和三线试验:一项前瞻性、交叉、对照研究。
Curr Ther Res Clin Exp. 2004 Jan;65(1):13-25. doi: 10.1016/S0011-393X(04)90001-X.
2
Furazolidone- and nitrofurantoin-resistant Helicobacter pylori: prevalence and role of genes involved in metronidazole resistance.对呋喃唑酮和呋喃妥因耐药的幽门螺杆菌:甲硝唑耐药相关基因的流行情况及作用
Antimicrob Agents Chemother. 2001 Jan;45(1):306-8. doi: 10.1128/AAC.45.1.306-308.2001.
3
Evaluation of nitrofurantoin combination therapy of metronidazole-sensitive and -resistant Helicobacter pylori infections in mice.
小鼠中甲硝唑敏感和耐药幽门螺杆菌感染的呋喃妥因联合疗法评估
Antimicrob Agents Chemother. 2000 Oct;44(10):2623-9. doi: 10.1128/AAC.44.10.2623-2629.2000.